DK1268775T3 - Höjt knoglemassegen af 11Q13.3 - Google Patents
Höjt knoglemassegen af 11Q13.3Info
- Publication number
- DK1268775T3 DK1268775T3 DK00941578T DK00941578T DK1268775T3 DK 1268775 T3 DK1268775 T3 DK 1268775T3 DK 00941578 T DK00941578 T DK 00941578T DK 00941578 T DK00941578 T DK 00941578T DK 1268775 T3 DK1268775 T3 DK 1268775T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- present
- bone mass
- gene
- diagnosing
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 238000000034 method Methods 0.000 abstract 5
- 230000014461 bone development Effects 0.000 abstract 3
- 239000003155 DNA primer Substances 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- -1 coding sequences Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 210000001650 focal adhesion Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002751 oligonucleotide probe Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000011664 signaling Effects 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Addiction (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/543,771 US6780609B1 (en) | 1998-10-23 | 2000-04-05 | High bone mass gene of 1.1q13.3 |
US09/544,398 US6770461B1 (en) | 1998-10-23 | 2000-04-05 | High bone mass gene of 11q13.3 |
PCT/US2000/016951 WO2001077327A1 (en) | 2000-04-05 | 2000-06-21 | THE HIGH BONE MASS GENE OF 11q13.3 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1268775T3 true DK1268775T3 (da) | 2009-03-16 |
Family
ID=32851157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00941578T DK1268775T3 (da) | 2000-04-05 | 2000-06-21 | Höjt knoglemassegen af 11Q13.3 |
Country Status (7)
Country | Link |
---|---|
US (2) | US6780609B1 (da) |
EP (1) | EP1964921A3 (da) |
AT (1) | ATE414772T1 (da) |
DE (1) | DE60040870D1 (da) |
DK (1) | DK1268775T3 (da) |
ES (1) | ES2316370T3 (da) |
ZA (1) | ZA200207883B (da) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6770461B1 (en) * | 1998-10-23 | 2004-08-03 | Genome Therapeutics Corporation | High bone mass gene of 11q13.3 |
US7514594B2 (en) * | 2001-05-11 | 2009-04-07 | Wyeth | Transgenic animal model of bone mass modulation |
EP2363480A3 (en) * | 2004-01-20 | 2015-10-07 | Isis Pharmaceuticals, Inc. | Modulation of glucocorticoid receptor expression |
CN103038258B (zh) | 2010-05-06 | 2017-02-15 | 诺华股份有限公司 | 用于治疗低密度脂蛋白相关蛋白质6(lrp6)的抗体的组合物及使用方法 |
AU2011249782B2 (en) | 2010-05-06 | 2014-10-02 | Novartis Ag | Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (LRP6) multivalent antibodies |
CN104039830A (zh) | 2011-11-04 | 2014-09-10 | 诺华股份有限公司 | 低密度脂蛋白相关蛋白6(lrp6)-半寿期延长物构建体 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
CA1188246A (en) | 1981-08-31 | 1985-06-04 | Jerry L. Gregory | Immobilized microbe recycle apparatus |
NZ207394A (en) | 1983-03-08 | 1987-03-06 | Commw Serum Lab Commission | Detecting or determining sequence of amino acids |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4973666A (en) | 1987-11-06 | 1990-11-27 | Washington Research Foundation | Peptide fragments containing HP and LP cross-links |
US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
IL103059A0 (en) | 1991-09-30 | 1993-02-21 | Boehringer Ingelheim Int | Conjugates for introducing nucleic acid into higher eucaryotic cells |
US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
TW366342B (en) | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
WO1997012903A1 (en) | 1995-10-04 | 1997-04-10 | Warner-Lambert Company | Compounds, compositions and methods for inhibiting the binding of proteins containing an sh2 domain to cognate phosphorylated proteins |
US5691153A (en) * | 1996-09-06 | 1997-11-25 | Creighton University | Genetic markers to detect high bone mass |
US5849902A (en) | 1996-09-26 | 1998-12-15 | Oligos Etc. Inc. | Three component chimeric antisense oligonucleotides |
US6555654B1 (en) | 1997-04-15 | 2003-04-29 | The Wellcome Trust Limited As Trustee For The Wellcome Trust | LDL-receptor |
US6545137B1 (en) | 1997-04-15 | 2003-04-08 | John A. Todd | Receptor |
BE1011331A6 (fr) | 1997-08-20 | 1999-07-06 | Univ Catholique De Louvain Hal | Polypeptide associe au peroxysome, sequence nucleotidique encodant ledit polypeptide et leur utilisation dans le diagnostic et/ou le traitement de maladies ou de lesions pulmonaires. |
FR2768747B1 (fr) | 1997-09-19 | 2000-12-01 | Pasteur Institut | Acides nucleiques, cellules recombinantes, et procede de preparation de compositions immunogenes |
JP2002506873A (ja) | 1998-03-18 | 2002-03-05 | アリアド・ファーマシューティカルズ・インコーポレイテッド | 複素環式シグナル伝達阻害剤、それを含む組成物 |
DE60129433T2 (de) * | 2000-05-26 | 2008-04-17 | Oscient Pharmaceuticals Corp., Waltham | Regulation des lipidniveaus über die gene zmax1 oder hbm |
EP1483288A4 (en) * | 2001-05-11 | 2005-09-21 | Genome Therapeutics Corp | HBM VARIANTS MODULATING BONE MASS AND LIPID LEVELS |
US8637506B2 (en) * | 2003-09-22 | 2014-01-28 | Enzo Biochem, Inc. | Compositions and methods for bone formation and remodeling |
KR102371587B1 (ko) | 2015-05-22 | 2022-03-07 | 현대자동차주식회사 | 횡단보도 인식 결과를 이용한 안내 정보 제공 장치 및 방법 |
-
2000
- 2000-04-05 US US09/543,771 patent/US6780609B1/en not_active Expired - Fee Related
- 2000-06-21 ES ES00941578T patent/ES2316370T3/es not_active Expired - Lifetime
- 2000-06-21 DE DE60040870T patent/DE60040870D1/de not_active Expired - Lifetime
- 2000-06-21 AT AT00941578T patent/ATE414772T1/de not_active IP Right Cessation
- 2000-06-21 DK DK00941578T patent/DK1268775T3/da active
- 2000-06-21 EP EP08006373A patent/EP1964921A3/en not_active Withdrawn
-
2002
- 2002-10-01 ZA ZA200207883A patent/ZA200207883B/xx unknown
-
2004
- 2004-04-29 US US10/834,377 patent/US20050142617A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1964921A2 (en) | 2008-09-03 |
ZA200207883B (en) | 2004-01-27 |
US20050142617A1 (en) | 2005-06-30 |
DE60040870D1 (de) | 2009-01-02 |
ES2316370T3 (es) | 2009-04-16 |
EP1964921A3 (en) | 2008-12-03 |
US6780609B1 (en) | 2004-08-24 |
ATE414772T1 (de) | 2008-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03010077A (es) | Abonadora de siembra a voleo con deflector movible. | |
WO2002092764A3 (en) | Transgenic animal model of bone mass modulation | |
ATE371727T1 (de) | Kdr, ein menschlicher tyrosin kinase rezeptor | |
ATE553201T1 (de) | Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismittel | |
EA199900939A1 (ru) | Остеопротегерин-связывающие белки и рецепторы | |
DK1124846T3 (da) | Nukleotid- og proteinsekvenser af Nogo-gener og derpå baserede fremgangsmåder | |
MXPA02009791A (es) | El gen de alta masa osea de 11q13.3. | |
ATE304052T1 (de) | Humane checkpointkinase, hcds1, zusammensetzungen und verfahren | |
DK1268775T3 (da) | Höjt knoglemassegen af 11Q13.3 | |
ATE329026T1 (de) | In knorpelgeweben stark exprimiertes gen | |
DK1285002T3 (da) | Regulering af lipidniveauer ved hjælp af ZMAX1- eller HBM-genet | |
ATE277171T1 (de) | Ikk-alpha proteine, nukleinsäuren und verfahren | |
FI940036A0 (fi) | Nukleotidisekvenssejä ja sykloheksimidiresistenssejä proteiineja | |
EA200000845A1 (ru) | Ген, кодирующий новый маркер рака | |
JP2005535289A5 (da) | ||
ATE483019T1 (de) | Aus einem neuroblastom in stufe 4s isoliertenukleinsäuren | |
Gronenborn et al. | Overproduction of the cyclic AMP receptor protein of Escherichia coli and expression of the engineered C-terminal DNA-binding domain | |
DK0778347T3 (da) | Protein med formodede helicase- og ATPase-egenskaber, som binder ATP og nukleinsyre | |
BR9811501A (pt) | Sequência de nucleotìdeos do gene nucleocapsìdeo de vìrus oropouche | |
DE69813837D1 (de) | Gen des familiären mittelmeerfiebers | |
MX9703970A (es) | Quimiocinas expresadas, su produccion y usos. |